PureTech Health (PRTC) to Release Earnings on Wednesday

PureTech Health (NASDAQ:PRTC) is scheduled to be posting its quarterly earnings results before the market opens on Wednesday, August 28th. Parties interested in participating in the company’s conference call can do so using this link.

PureTech Health Price Performance

PRTC opened at $22.45 on Monday. The business’s fifty day simple moving average is $23.20 and its 200-day simple moving average is $25.86. PureTech Health has a 12-month low of $17.08 and a 12-month high of $34.00.

PureTech Health Company Profile

PureTech Health plc, engages in the development and commercialization of biotechnology and pharmaceutical solutions in the United States. The company is developing LYT-100, which is under Phase 2 stage, to treat idiopathic pulmonary fibrosis (IPF); and LYT-200, a IgG4 monoclonal antibody, currently under Phase 1/2 stage, targeting galectin-9 for treating solid tumors and hematological malignancies.